Nature’s Sunshine Products (NASDAQ:NATR) EVP Sells $262,407.60 in Stock

Nature’s Sunshine Products, Inc. (NASDAQ:NATRGet Free Report) EVP Nathan Brower sold 12,015 shares of the firm’s stock in a transaction that occurred on Thursday, May 21st. The stock was sold at an average price of $21.84, for a total transaction of $262,407.60. Following the sale, the executive vice president directly owned 43,438 shares of the company’s stock, valued at approximately $948,685.92. This trade represents a 21.67% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Nature’s Sunshine Products Price Performance

Shares of Nature’s Sunshine Products stock traded up $0.01 during trading on Friday, reaching $21.87. 20,495 shares of the company traded hands, compared to its average volume of 115,660. Nature’s Sunshine Products, Inc. has a 1-year low of $12.97 and a 1-year high of $28.14. The company has a 50 day moving average price of $24.80 and a 200-day moving average price of $23.57. The firm has a market capitalization of $384.39 million, a PE ratio of 19.88 and a beta of 0.95.

Nature’s Sunshine Products (NASDAQ:NATRGet Free Report) last posted its quarterly earnings results on Thursday, May 7th. The company reported $0.30 EPS for the quarter, topping analysts’ consensus estimates of $0.20 by $0.10. Nature’s Sunshine Products had a net margin of 4.06% and a return on equity of 14.67%. The business had revenue of $122.89 million during the quarter, compared to analysts’ expectations of $122.15 million.

Analysts Set New Price Targets

A number of analysts recently commented on the company. DA Davidson reaffirmed a “buy” rating and issued a $33.00 target price on shares of Nature’s Sunshine Products in a research report on Monday, May 11th. Weiss Ratings raised Nature’s Sunshine Products from a “buy (b-)” rating to a “buy (b)” rating in a research note on Monday, May 11th. Finally, Canaccord Genuity Group set a $37.00 price objective on Nature’s Sunshine Products in a report on Friday, May 8th. Three analysts have rated the stock with a Buy rating, According to MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of $35.00.

Get Our Latest Analysis on NATR

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the business. Dimensional Fund Advisors LP raised its holdings in shares of Nature’s Sunshine Products by 2.2% in the 3rd quarter. Dimensional Fund Advisors LP now owns 913,791 shares of the company’s stock worth $14,181,000 after acquiring an additional 20,037 shares during the last quarter. Vanguard Group Inc. boosted its stake in Nature’s Sunshine Products by 15.3% during the 3rd quarter. Vanguard Group Inc. now owns 803,104 shares of the company’s stock valued at $12,464,000 after purchasing an additional 106,688 shares during the last quarter. Kennedy Capital Management LLC boosted its stake in Nature’s Sunshine Products by 14.6% during the 3rd quarter. Kennedy Capital Management LLC now owns 675,764 shares of the company’s stock valued at $10,488,000 after purchasing an additional 86,128 shares during the last quarter. Renaissance Technologies LLC increased its holdings in Nature’s Sunshine Products by 1.5% during the 1st quarter. Renaissance Technologies LLC now owns 531,924 shares of the company’s stock worth $12,761,000 after purchasing an additional 7,827 shares in the last quarter. Finally, Geode Capital Management LLC raised its stake in shares of Nature’s Sunshine Products by 0.6% in the fourth quarter. Geode Capital Management LLC now owns 360,546 shares of the company’s stock worth $7,782,000 after purchasing an additional 1,980 shares during the last quarter. 79.40% of the stock is currently owned by institutional investors and hedge funds.

Nature’s Sunshine Products Company Profile

(Get Free Report)

Nature’s Sunshine Products, Inc is a global manufacturer and direct seller of nutritional supplements, herbal remedies, and personal care products. The company’s core business centers on research, development and distribution of vitamins, minerals, botanicals and essential oil-based formulations designed to support overall health and wellness. Operating under a network-marketing model, Nature’s Sunshine works through a network of independent distributors who promote and sell its product line directly to consumers.

The company’s product portfolio spans dietary supplements such as single-ingredient vitamins, proprietary herbal blends, sports nutrition formulas and weight-management solutions, along with skin and hair care items based on botanical extracts and essential oils.

See Also

Insider Buying and Selling by Quarter for Nature's Sunshine Products (NASDAQ:NATR)

Receive News & Ratings for Nature's Sunshine Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nature's Sunshine Products and related companies with MarketBeat.com's FREE daily email newsletter.